News

Press Releases

Oct 27, 2022

CRISPR Therapeutics Announces Planned Transition of Chief Operating Officer

Oct 05, 2022

CRISPR Therapeutics to Present at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting

Sep 29, 2022

CRISPR Therapeutics to Present at the BMO Biopharma Spotlight Series: Gene Editing and Therapy

Sep 28, 2022

CRISPR Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to CTX130™ for the Treatment of Cutaneous T-Cell Lymphomas (CTCL)

View All Press

Presentations

Sep 29, 2022

9/29 Release

Sep 27, 2022

9/27/22 Release

Sep 22, 2022

CRISPR Therapeutics Corporate Presentation

Sep 06, 2022

8/31/2022 Press Release

View All Presentations

Events

Wednesday, June 13, 2018 8:00 a.m. PT

CRISPR Therapeutics at Goldman Sachs 39th Annual Global Healthcare Conference

You are now leaving the CRISPR Therapeutics website.

CRISPR Therapeutics is not responsible for the content or availability of third-party sites.

Continue